The substrate of increased cortical FA in MS: A 7T post-mortem MRI and histopathology study

Abstract

Background:

Using diffusion tensor imaging (DTI), it was previously found that demyelinated gray matter (GM) lesions have increased fractional anisotropy (FA) when compared to normal-appearing gray matter (NAGM) in multiple sclerosis (MS). The biological substrate underlying this FA change is so far unclear; both neurodegenerative changes and microglial activation have been proposed as causal contributors.

Objective:

To test the proposed hypothesis that microglia activation is responsible for increased FA in cortical GM lesions.

Methods:

We investigated post-mortem cortical DTI changes in hemispheric, coronally cut sections and investigated the underlying histopathology using immunohistochemistry.

Results:

Overall, there were few activated microglia/macrophages, and no difference between GM lesions and NAGM was observed. However, cell density was increased in GM lesions compared to NAGM (309.67 ± standard deviation (SD) 124.44 vs 249.95 ± SD 56.75, p = 0.002).

Conclusion:

FA increase was not due to lesional and non-lesional differences in microglia activation and/or proliferation. We found an increase in general cellular density without a notable difference in cellular size, that is, tissue compaction, as a possible alternative explanation.

Keywords

DTI FA MD 7T MRI histopathology cortical lesions multiple sclerosis

Get full access to this article

View all access options for this article.

References

Nelson

Datta

Garcia

. et al. Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler 2011; 17: 1122–1129.

Roosendaal

Moraal

Pouwels

. et al. Accumulation of cortical lesions in MS: Relation with cognitive impairment. Mult Scler 2009; 15: 708–714.

Seewann

Vrenken

Kooi

. et al. Imaging the tip of the iceberg: Visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17: 1202–1210.

Seewann

Kooi

Roosendaal

. et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302–308.

Jonkman

Klaver

Fleysher

. et al. Ultra-high-field MRI visualization of cortical multiple sclerosis lesions with T2 and T2*: A postmortem MRI and histopathology study. Am J Neuroradiol 2015; 36: 2062–2067.

Calabrese

Rinaldi

Seppi

. et al. Cortical diffusion-tensor imaging abnormalities in multiple sclerosis: A 3-year longitudinal study. Radiology 2011; 261: 891–898.

Poonawalla

Hasan

Gupta

. et al. Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: Initial findings. Radiology 2008; 246: 880–886.

Filippi

Preziosa

Pagani

. et al. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis. Mult Scler 2013; 19: 418–426.

Bester

Jensen

Babb

. et al. Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult Scler 2015; 21: 935–944.

10.

Politis

Giannetti

. et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology 2012; 79: 523–530.

11.

Klaver

Popescu

Voorn

. et al. Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis. J Neuropathol Exp Neurol 2015; 74: 453–458.

12.

Vedeler

Nyland

. et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003; 9: 323–331.

13.

Peterson

Mork

. et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389–400.

14.

Jenkinson

Beckmann

Behrens

Woolrich

Smith

SM.

Fsl. NeuroImage 2012; 62: 782–790.

15.

Vedeler

Nyland

. et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723–732.

16.

Rodriguez

Wegner

Kreutzfeldt

. et al. Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination. Acta Neuropathol 2014; 128: 231–246.

17.

Kooi

Strijbis

van der Valk

. et al. Heterogeneity of cortical lesions in multiple sclerosis: Clinical and pathologic implications. Neurology 2012; 79: 1369–1376.

18.

Brink

Veerhuis

Breij

. et al. The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005; 64: 147–155.

19.

Van Horssen

Brink

de Vries

. et al. The blood-brain barrier in cortical multiple sclerosis lesions. J Neuropathol Exp Neurol 2007; 66: 321–328.

20.

Popescu

Klaver

Voorn

. et al. What drives MRI-measured cortical atrophy in multiple sclerosis? Mult Scler 2015; 21: 1280–1290.

21.

Miller

Tang

. et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells. Ann Neurol 2009; 65: 304–315.

22.

Chang

Staugaitis

Dutta

. et al. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol 2012; 72: 918–926.

23.

Schonrock

Kuhlmann

Adler

. et al. Identification of glial cell proliferation in early multiple sclerosis lesions. Neuropathol Appl Neurobiol 1998; 24: 320–330.

24.

Miller

Stagg

Douaud

. et al. Diffusion imaging of whole, post-mortem human brains on a clinical MRI scanner. Neuroimage 2011; 57: 167–181.